Chronic obstructive pulmonary disease subtypes. transitions over time

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Esteban, Cristóbal ^a,b   Arostegui, Inmaculada ^b,c,d   Aburto, Myriam ^a   Moraza, Javier ^a   Quintana, José M ^a,b   García Loizaga, Amaia ^a   Basualdo, Luis V ^a   Aramburu, Amaia ^a   Aizpiri, Susana ^a   Uranga, Ane ^a   Capelastegui, Alberto ^a  

^a HOSPITAL DE GALDAKAO   (Spain)

^b Basurto University Hospital Health Service Research Network on Chronic Diseases (REDISSEC)   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d BCAM BASQUE CENTER FOR APPLIED MATHEMATICS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE SUBTYPE A; CHRONIC OBSTRUCTIVE LUNG DISEASE SUBTYPE B; CHRONIC OBSTRUCTIVE LUNG DISEASE SUBTYPE C; CHRONIC OBSTRUCTIVE LUNG DISEASE SUBTYPE D; CLUSTER ANALYSIS; COHORT ANALYSIS; COMORBIDITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSPNEA; FEMALE; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; PHYSICAL ACTIVITY; PHYSICAL CAPACITY; QUALITY OF LIFE; EXERCISE TOLERANCE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; CLUSTER ANALYSIS; COMORBIDITY; DYSPNEA; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE;

EID: 84991232867     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0161710     Document Type: Article

References (39)

1. Dornhorst AC. Respiratory insufficiency (Frederick Price Memorial Lecture). Lancet 1955; 1: 1185-1187.
2. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11:122. doi: 10.1186/1465-9921-11-122 PMID: 20831787
3. Vestbo J, Hurd SS, Agustí AG, Jones C, Vogelmeier A, Anzueto P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365. doi: 10.1164/rccm.201204-0596PP PMID: 22878278
4. Miravitlles M, Soler-Cataluña JJ, Calle M, Soriano JB. Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Eur Respir J 2013; 41:1252-1256. doi: 10.1183/09031936. 00118912 PMID: 23060631
5. Celli BC, Cote CG, Marín JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012. PMID: 14999112
6. Burgel PR, Paillasseur JL, Caillaud D, Tillie-Leblond I, Chanez P, Escamilla R, et al. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J 2010; 36: 531-539. doi: 10.1183/09031936.00175109 PMID: 20075045
7. Garcia-Aymerich J, Gómez FP, Benet M, Farrero E, Basagaña X, Gayete A, et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 2011; 66: 430-437. doi: 10.1136/thx.2010.154484 PMID: 21177668
8. Burgel PR, Paillasseur JL, Peene B, Dusser D, Roche N, Coolen J, et al. Two Distinct Chronic Obstructive Pulmonary Disease (COPD) Phenotypes Are Associated with High Risk of Mortality. PLOS One 2012; 7:e51048. doi: 10.1371/journal.pone.0051048 PMID: 23236428
9. Rennard SI, Locantore N, Delafont B, Tal-Singer R, Silverman EK, Vestbo J, et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints. Identification of Five Chronic Obstructive Pulmonary Disease Subgroups with Different Prognoses in the ECLIPSE Cohort Using Cluster Analysis. Ann Am Thorac Soc 2015; 12: 303-312. doi: 10.1513/AnnalsATS.201403-125OC PMID: 25642832
10. Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med 2011; 184: 662-671. doi: 10.1164/rccm.201104-0597OC PMID: 21680942
11. Arostegui I, Esteban C, García-Gutierrez S, Bare M, Fernández-de-Larrea N, Briones E, et al; IRYSS-COPD Group. Subtypes of Patients Experiencing Exacerbations of COPD and Associations with Outcomes. PLoS ONE 2014; 9(6): e98580. doi: 10.1371/journal.pone.0098580 PMID: 24892936
12. Mahler DA, Ward J, Waterman LA, McCusker C, Zuwallack R, Baird JC. Patient-reported dyspnea in COPD reliability and association with stage of disease. Chest 2009; 136: 1473-1479. doi: 10.1378/ chest.09-0934 PMID: 19696126
13. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383. PMID: 3558716
14. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991: 85(Suppl B): 25-31. PMID: 1759018
15. Ferrer M, Alonso J, Prieto L, Plaza V, Monsó E, Marrades R, et al. Validity and reliability of the St George's Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example. Eur Respir J 1996; 9: 1160-1166. PMID: 8804932
16. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006; 61: 772-778. PMID: 16738033
17. Schnohr P, Scharling H, Jensen JS. Changes in leisure time physical activity and risk of death: An observational study of 7000 men and women. Am J Epidemiol 2003; 158: 639-644. PMID: 14507599
18. Manual SEPAR de Procedimientos. Módulo 4. Procedimientos de evaluación de la función pulmonar-II. Barcelona, Spain: Publicaciones Permanyer; 2004.
19. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function test, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J 1993; 16:5-40.
20. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111-117. PMID: 12091180
21. Mathiowetz V, Kashman N, Volland G, Weber K, Dowe M, Rogers S. Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil 1985; 66:69-74. PMID: 3970660
22. Bohannon RW. Responsiveness of measurements of knee extension force obtained by hand-held dynamometry. Isokinet Exerc Sci 2009; 17:169-172.
23. Benzécri JP. Statistical analysis as a tool to make patterns emerge from data. In: Watanabe S. Methodologies of Pattern Recognition. New York: Academic Press. 1969; 35-74.
24. Greenacre M. Correspondence analysis in medical research. Stat Methods Med Res 1992; 1: 97-117. PMID: 1341654
25. Jambu M. Classification Automatique pour l'Analyse des Donnés. Tome1: Méthodes et Algoritmes. Paris: Dunod; 1978.
26. Ward JH. Hierarchical grouping to optimize an objective function. J Am Stat Assoc 1963; 58: 236-244.
27. R development Core Team. R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria, 2010; Available: http://cran.r-project.org/.
28. Lange P, Marott JL, Vestbo J, Olsen KR, Ingebrigtsen TS, Dahl M, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med 2012; 186: 975-981. doi: 10.1164/rccm.201207-1299OC PMID: 22997207
29. Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32: 962-969. doi: 10.1183/09031936. 00012408 PMID: 18579551
30. Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, Bruijnzeel PL, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187: 728-735 doi: 10.1164/ rccm.201209-1665OC PMID: 23392440
31. Almagro P, Cabrera FJ, Diez J, Boixeda R, Alonso-Ortiz MB, Barreiro B, et al. Comorbidities and shortterm prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. Chest 2012; 142: 1126-1133. doi: 10.1378/chest.11-2413 PMID: 23303399
32. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, et al. BODE Collaborative Group. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186: 155-161. doi: 10.1164/rccm.201201-0034OC PMID: 22561964
33. Casanova C, de Torres JP, Aguirre-Jaíme A, Pinto-Plata V, Marin JM, Cordoba E, et al. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. Am J Respir Crit Care Med. 2011; 184:1015-1021. doi: 10.1164/rccm.201105-0831OC PMID: 21836135
34. Pinto-Plata VM, Cote C, Cabral H, Taylor J, Celli BR. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004; 23: 28-33. PMID: 14738227
35. Esteban C, Quintana JM, Aburto M, Moraza J, Egurrola M, Pérez-Izquierdo J, et al. Impact of changes in physical activity on health-related quality of life among patients with COPD. Eur Respir J 2010; 36: 292-300. doi: 10.1183/09031936.00021409 PMID: 20075059
36. Esteban C, Arostegui I, Aburto M, Moraza J, Quintana JM, Aizpiri S, et al. Influence of changes in physical activity on frequency of hospitalization in chronic obstructive pulmonary disease. Respirology 2014; 19: 330-338. doi: 10.1111/resp.12239 PMID: 24483954
37. Swallow EB, Reyes D, Hopkinson NS, Man WD, Porcher R, Cetti EJ, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007; 62:115-120. PMID: 17090575
38. Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178: 218-224. doi: 10.1164/rccm.200711-1754OC PMID: 18480428
39. Weatherall M, Travers J, Shirtcliffe PM, Marsh SE, Williams MV, Nowitz MR, et al. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J 2009; 34: 812-818. doi: 10.1183/ 09031936.00174408 PMID: 19357143